Elevai Biosciences, a Subsidiary of Elevai Labs (ELAB), Expands Patent Portfolio
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: ELAB) | Delayed: 1.94 -0.16 (7.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.10 | 52 Week High | $ | |||
| Open | $1.91 | 52 Week Low | $ | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $1.86 | EPS | $ | |||
| Volume | 225,171 | |||||
